Benign fibrous histiocytoma of the oral and maxillofacial region: A systematic review

Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Feb;133(2):e43-e56. doi: 10.1016/j.oooo.2021.07.003. Epub 2021 Jul 15.

Abstract

Objective: The aim of the present study was to carry out a systematic review of available data regarding case reports and case series of oral and maxillofacial benign fibrous histiocytoma (BFH).

Study design: A search strategy was performed using the PubMed, Web of Science, Scopus, and EMBASE electronic databases.

Results: Male individuals (56.89%) were more affected, with a mean age of 34.55 ± 20 years. The buccal mucosa (20.33%) represented the most common site, with the clinical presentation of a painless (86.95%) nodule (98.03%). The clinical hypothesis of a fibroma was reported in most cases (31.57%). Radiographic presentation of intraosseous lesions showed multilocular radiolucent images (55.55%). Regarding the histopathologic features, the biphasic population of fibroblastic and histiocytic cells was seen in 21 cases (39.62%), and a spindle-shaped fibroblastic cell population organized into a storiform pattern was observed in 25 cases (47.16%). CD68 (n = 26) and vimentin (n = 25) showed immunoreactivity in all BFH cases in which they were used. All cases were treated with a surgical resection, and 8.10% recurred.

Conclusions: The current systematic review demonstrated that BFH represents a rare lesion that mainly affects the buccal mucosa of male individuals, and the treatment is mainly surgical with a good prognosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Head
  • Histiocytoma, Benign Fibrous* / diagnostic imaging
  • Histiocytoma, Benign Fibrous* / pathology
  • Histiocytoma, Benign Fibrous* / surgery
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Young Adult